Humanigen Inc (fka HGENQ)

[DonDonDonDon]

I keep coming back to the overall success that the Mayo Clinic has had treating Covid. 1% of those treated for Covid at Mayo passed away. The national average is 3%. That is circumstantially perfect for lenz having a great trial. And Mayo's ICU mortality rate is 11.9% which is incredibly low and could only have been achieved if lenz is super effective.

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-model-of-care-and-research-leads-to-favorable-outcomes-for-patients-with-covid-19/
Included in the research during the study period were 7,891 patients who tested positive for COVID-19 and were treated at Mayo Clinic. Of those patients, 897 required hospitalization ? 354 in an ICU. An intensive, multilayered approach was used to manage patient care, leveraging clinical trials and available therapies, and using remote monitoring tools for patients before or after hospital care.

Just over 77.5% of hospitalized patients received at least one COVID-19 therapy, such as an antiviral drug, systemic steroid, immunomodulatory monoclonal antibody or convalescent plasma. Nearly one-quarter of hospitalized patients received two therapies, most commonly a combination of steroids and antiviral medications.

The research, published in Mayo Clinic Proceedings, finds that mortality rates were lower than the national and international averages, and lower than what has been reported in other major studies and expanded-access programs. An overall mortality rate of 1.1% was reported for patients treated at Mayo, with inpatient mortality of 7.1% and ICU mortality of 11.9%.